- Home
- Products
- Customized FluoroAb™
- C5
- Anti-C5 MAb (Clone 7)-iFluor® 488 Succinimidyl Ester
Anti-C5 MAb (Clone 7)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10319)
This product is comprised of an Chimeric Anti-C5 IgG1-kappa (Clone 7) labeled with iFluor® 488 Succinimidyl Ester. iFluor® 488 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- C5
- Alternative Names
- C5; complement component 5; complement C5; CPAMD4; anaphylatoxin C5a analog; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4; FLJ17816; FLJ17822; MGC142298;
- Overview
- This gene encodes a component of the complement system, a part of the innate immune system that plays an important role in inflammation, host homeostasis, and host defense against pathogens. The encoded preproprotein is proteolytically processed to generate multiple protein products, including the C5 alpha chain, C5 beta chain, C5a anaphylatoxin and C5b. The C5 protein is comprised of the C5 alpha and beta chains, which are linked by a disulfide bridge. Cleavage of the alpha chain by a convertase enzyme results in the formation of the C5a anaphylatoxin, which possesses potent spasmogenic and chemotactic activity, and the C5b macromolecular cleavage product, a subunit of the membrane attack complex (MAC). Mutations in this gene cause complement component 5 deficiency, a disease characterized by recurrent bacterial infections. Alternative splicing results in multiple transcript variants.
- Overview
- Chimeric Anti-C5 IgG1-kappa (Clone 7)
- Species Reactivity
- Human
- Name
- iFluor® 488 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 491/516
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-IL1B MAb (Clone 7)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS12092)
- Anti-ANGPTL3 MAb (Clone 2)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4712)
- Anti-HGF MAb (Clone 5)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS12033)
- Anti-FAP MAb (Clone 1)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6369)
- Anti-CSF2 MAb (Clone 2)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16158)
- Anti-CD40LG MAb (Clone 6)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11955)
- Anti-CD4 MAb (Clone 14)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4223)
- Anti-BSG MAb (Clone 3)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2367)
- Muromonab-Bodipy FL (CAT#: ADC-FL-606)
- Anti-TGFB1 MAb (Clone 2)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3775)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS10319. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-731 | Anti-C5 (Eculizumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-732 | Anti-C5 (Eculizumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-737 | Anti-C5 (Pexelizumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-734 | Anti-C5 (Pexelizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-728 | Anti-C5 (Eculizumab)-SMCC-DM1 ADC | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
